Quick Answer
Boundless Bio, Inc. reported Total Assets of $157.06 million for the year ending 2025.
- Boundless Bio, Inc. showed a decrease of -23.9% in Total Assets from 2024 to 2025.
- This data is from Boundless Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: $117.08 million | Q2 2024: $188.20 million | Q3 2024: $175.09 million | Q1 2025: $191.24 million | Q2 2025: $179.45 million | Q3 2025: $168.72 million.
- Over the full 3 years of available data (2023 to 2025), Boundless Bio, Inc.'s Total Assets has grown by 20.9%.
- Historical annual values: Fiscal year 2025: $157.06 million | Fiscal year 2024: $206.41 million | Fiscal year 2023: $129.89 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: